Financial reports
NT 10-K
Notice of late annual filing
1 Apr 24
NT 10-Q
Notice of late quarterly filing
16 Nov 23
10-Q
2023 Q2
Quarterly report
18 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
10-Q
2023 Q1
Quarterly report
11 Jul 23
10-K
2022 FY
Annual report
29 Jun 23
NT 10-Q
Notice of late quarterly filing
15 May 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
21 Nov 22
NT 10-Q
Notice of late quarterly filing
14 Nov 22
Current reports
8-K
Akari Therapeutics and Peak Bio Announce Definitive Agreement to
5 Mar 24
8-K
Unregistered Sales of Equity Securities
21 Feb 24
8-K
Unregistered Sales of Equity Securities
6 Feb 24
8-K
Entry into a Material Definitive Agreement
29 Jan 24
8-K
Unregistered Sales of Equity Securities
3 Jan 24
8-K
Entry into a Material Definitive Agreement
22 Dec 23
8-K
Unregistered Sales of Equity Securities
2 Nov 23
8-K
Departure of Directors or Certain Officers
30 Aug 23
8-K
Entry into a Material Definitive Agreement
15 Aug 23
8-K
Unregistered Sales of Equity Securities
21 Jul 23
Registration and prospectus
425
Business combination disclosure
5 Mar 24
425
Business combination disclosure
5 Mar 24
424B3
Prospectus supplement
10 Aug 23
424B3
Prospectus supplement
10 Aug 23
POS AM
Prospectus update (post-effective amendment)
3 Aug 23
POS AM
Prospectus update (post-effective amendment)
24 Jul 23
424B3
Prospectus supplement
17 Mar 23
25-NSE
Exchange delisting
3 Mar 23
424B3
Prospectus supplement
1 Mar 23
S-1/A
IPO registration (amended)
14 Feb 23
Proxies
DEF 14A
Definitive proxy
18 Oct 22
DEFA14A
Additional proxy soliciting materials
18 Oct 22
PRER14A
Preliminary revised proxy
17 Oct 22
PRER14A
Preliminary revised proxy
13 Oct 22
DEFM14A
Proxy related to merger
6 Oct 22
PRER14A
Preliminary revised proxy
6 Oct 22
PRER14A
Preliminary revised proxy
3 Oct 22
DEFA14A
Additional proxy soliciting materials
28 Sep 22
PRER14A
Preliminary revised proxy
26 Sep 22
PRE 14A
Preliminary proxy
23 Sep 22
Other
EFFECT
Notice of effectiveness
11 Aug 23
CORRESP
Correspondence with SEC
3 Aug 23
UPLOAD
Letter from SEC
1 Aug 23
EFFECT
Notice of effectiveness
2 Mar 23
CORRESP
Correspondence with SEC
27 Feb 23
CORRESP
Correspondence with SEC
14 Feb 23
UPLOAD
Letter from SEC
6 Feb 23
CORRESP
Correspondence with SEC
31 Jan 23
UPLOAD
Letter from SEC
18 Jan 23
CORRESP
Correspondence with SEC
4 Jan 23